Bruce A Goldsmith Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bruce A Goldsmith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bruce A Goldsmith. Bruce A Goldsmith is a SVP, Corporate Development in ALLOS THERAPEUTICS INC ($ALTH) and a VP, Corporate Development in ALLOS THERAPEUTICS INC ($ALTH) and a CEO and President in Passage BIO, Inc. ($PASG).
Address: 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER 80020 CO
Companies in which Bruce A Goldsmith is an Insider
ALLOS THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bruce A Goldsmith: SVP, Corporate Development, VP, Corporate Development
Holdings: 0 shares
Latest Transaction: Sep 05 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Passage BIO, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Bruce A Goldsmith: CEO and President
Holdings: 0 shares
Latest Transaction: Feb 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Bruce A Goldsmith
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | PASG | Passage BIO, Inc. | Goldsmith Bruce A | CEO and President | Option Exercise | A | 21.85 | 262,000 | 5,724,700 | 262,000 | |
| Sep 05 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | U | 1.82 | 346,933 | 631,418 | 0 | 346.9 K to 0 (-100.00 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.50 | 4,473 | 6,690 | 346,933 | 351.4 K to 346.9 K (-1.27 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.52 | 4,505 | 6,869 | 351,406 | 355.9 K to 351.4 K (-1.27 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Grant | A | 0.00 | 179,727 | 0 | 355,911 | 176.2 K to 355.9 K (+102.01 %) |
| Feb 27 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.54 | 575 | 888 | 176,184 | 176.8 K to 176.2 K (-0.33 %) |
| Feb 27 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.58 | 2,500 | 3,958 | 176,759 | 179.3 K to 176.8 K (-1.39 %) |